Pathogenesis and therapeutic targeting of immune disorders
Pathogenesis and therapeutic targeting of immune disorders
批准号:
9149365
负责人:
David A Hildeman
金额:
$14.06万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2021-06-30
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
Dysregulated immune responses are of central importance to the pathogenesis and expression of a wide
spectrum of diseases that cause an immense burden of morbidity and mortality. The overall Aim of the training
grant is to provide training for 3 pre-doctoral candidates, whose research will uncover pathogenic mechanisms
of immune-mediated disease and facilitate transformative therapeutic approaches, consistent with the mission
of the NIH. Candidates will be recruited from the Immunology Graduate Program (ImmGP) and the Medical
Scientist Training Program at Cincinnati Children’s Hospital Medical Center (CCHMC) and the University of
Cincinnati College of Medicine (UCCOM). Housed within CCHMC, one of the premiere pediatric research
institutions in the US, the ImmGP attracts a strong and diverse pool of applicants. ImmGP students receive
exemplary didactic instruction in immunology, research ethics, grant writing, and biostatistics. The training
program will be led by a Director and Co-Director (Drs. Hildeman and Singh) who, along with 34 outstanding
Training Faculty (TF), have significant experience in mentoring pre-doctoral students. Students will work with a
diverse group of TF (comprised of MDs, MD/PhDs, and PhDs), from multiple departments at CCHMC/UCCOM,
who share a collective focus on the mechanistic understanding of the immunologic basis of human disease.
Students in this training program will be immersed in a distinctive environment: TF have well-funded research
programs that span basic immunology to animal models of disease to clinical trials in human patients; CCHMC
provides tremendous institutional resources (e.g., support for graduate education and faculty research, cutting-
edge core facilities, unique patient cohorts); a collaborative research student exchange program with a
German University and Research Institute provides a unique opportunity for international studies in
immunology. Graduates of this program will be uniquely poised to bring innovations in immunology from the
laboratory bench to the bedside and will be well-prepared for independent research careers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis and therapeutic targeting of immune disorders
-
批准号:9308845
-
项目类别:
-
资助金额:$14.21万
-
财政年份:2016
-
负责人:David A Hildeman
-
依托单位:
Pathogenesis and therapeutic targeting of immune disorders
-
批准号:9925180
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2016
-
负责人:David A Hildeman
-
依托单位:
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire
-
批准号:9054073
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2014
-
负责人:David A Hildeman
-
依托单位:
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire
-
批准号:8780156
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2014
-
负责人:David A Hildeman
-
依托单位:
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire
-
批准号:9248785
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2014
-
负责人:David A Hildeman
-
依托单位:
Control of Diabetes by Manipulation of Bc12 Family Members
-
批准号:8130455
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2011
-
负责人:David A Hildeman
-
依托单位:
Control of Diabetes by Manipulation of Bc12 Family Members
-
批准号:8502469
-
项目类别:
-
资助金额:$32.11万
-
财政年份:2011
-
负责人:David A Hildeman
-
依托单位:
Control of Diabetes by Manipulation of Bc12 Family Members
-
批准号:8690027
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2011
-
负责人:David A Hildeman
-
依托单位:
Control of Diabetes by Manipulation of Bc12 Family Members
-
批准号:8294697
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2011
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T Cells
-
批准号:8079306
-
项目类别:
-
资助金额:$10.23万
-
财政年份:2010
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T cells
-
批准号:7242520
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T Cells
-
批准号:8389656
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T cells
-
批准号:7071090
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T cells
-
批准号:6983776
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T Cells
-
批准号:8197073
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T Cells
-
批准号:7743075
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
IL-1 dependent anorexia during CNS viral infection
-
批准号:7039268
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
IL-1 dependent anorexia during CNS viral infection
-
批准号:7318492
-
项目类别:
-
资助金额:$16.39万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T Cells
-
批准号:7581426
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
Regulation of Apoptosis in Activated Primary T Cells
-
批准号:7990436
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2005
-
负责人:David A Hildeman
-
依托单位:
海外基金